ADVISORY BOARD

Gregory Stock

Gregory Stock is the Director of the Program on Medicine, Technology, and Society at UCLAıs School of Public Health. In this role he explores critical technologies poised to have large impacts on humanityıs future and the shape of medical science. His goal has been to bring about a broad public debate on these technologies and their implications, leading to wise public policies surrounding their realization. Of particular interest to the program are the implications for society, medicine, and business of the human genome project and associated developments emerging from today's revolution in molecular genetics and bioinformatics. The Storefront Genome, the symposium he convened in January 2003 to consider the broad challenges that cheap, easy access to our genetic constitutions will bring drew wide media attention, and his 1998 look at the possibilities of manipulating the genetics of human embryos, the first major public discussion of this issue among distinguished scientists, opened a global debate on this then taboo topic.

A prolific author and recognized authority on the impact of new technologies on human society, Professor. Stock's 2002 book, Redesigning Humans: Our Inevitable Genetic Future with Houghton Mifflin, won the Kistler Book Prize for Science books and was nominated for a Wired Rave Award. Among his other books are Engineering The Human Germline for Oxford University Press, Metaman for Simon & Schuster, and the best seller, The Book of Questions, which has been translated into seventeen languages, and is now in its fifty-fifth printing. Sequels to that book include The Book of Questions: Business, Politics, and Ethics and a new book that will explore how coming technologies will reshape our everyday lives.

Dr. Stock has been an invited speaker to numerous academic, government, and business conferences, sits on the editorial board of the American Journal of Bioethics, and was asked to submit an Advisory Memo to the President on the challenges of the next century. He makes regular appearances on television and radio, including CNN, PBS, NPR, Bloomberg, and the BBC. He has debated biotech policy with Jeremy Rifkin, Leon Kass, Francis Fukuyama, and other prominent voices who would rein in biomedical research, and he is hosting a television special later this year on key figures in today's biotech revolution.

Gregory Stock has a Doctorate in Biophysics from Johns Hopkins University, and an MBA from Harvard University and currently has appointments at Princeton University and UCLA's School of Public Health.